Normal mitral cell dendritic development in the setting of Mecp2 mutation

Neuroscience

Volumn 202, Issue , 2012, Pages 108-116

  Palmer, A M ^a   Degano, A L ^a   Park, M J ^a   Ramamurthy, S ^a   Ronnett, G V ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism spectrum disorder; Dendrite development; Mecp2; Mitral cell; Olfaction; Rett syndrome

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL DISRUPTION; CELL SIZE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITE; GENE MUTATION; MALE; METHYL CPG BINDING PROTEIN 2 GENE; MITRAL CELL; MOUSE; MOUSE MUTANT; MUTATIONAL ANALYSIS; MUTATOR GENE; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; NONHUMAN; OLFACTORY BULB; OLFACTORY SYSTEM; PRIORITY JOURNAL; RETT SYNDROME; SENSORY NERVE CELL; SYNAPTIC MEMBRANE; TARGET CELL; WILD TYPE;

ANIMALS; AUTISTIC DISORDER; AXONS; DATA INTERPRETATION, STATISTICAL; DENDRITES; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MUTATION; NEURITES; OLFACTORY BULB; OLFACTORY RECEPTOR NEURONS; RETT SYNDROME; SYNAPSES;

EID: 84856230354     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.044     Document Type: Article

References (61)

1. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23(2):185-188.
2. Armstrong D., Dunn J.K., Antalffy B., Trivedi R. Selective dendritic alterations in the cortex of Rett syndrome. J Neuropathol Exp Neurol 1995, 54(2):195-201.
3. Armstrong D.D. Rett syndrome neuropathology review 2000. Brain Dev 2001, 23(Suppl 1):S72-S76.
4. Asaka Y., Jugloff D.G., Zhang L., Eubanks J.H., Fitzsimonds R.M. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis 2006, 21(1):217-227.
5. Ballas N., Lioy D.T., Grunseich C., Mandel G. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 2009, 12(3):311-317.
6. Bauman M.L., Kemper T.L., Arin D.M. Microscopic observations of the brain in Rett syndrome. Neuropediatrics 1995, 26(2):105-108.
7. Belichenko N.P., Belichenko P.V., Mobley W.C. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiol Dis 2009, 34(1):71-77.
8. Belichenko P.V., Oldfors A., Hagberg B., Dahlström A. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 1994, 5(12):1509-1513.
9. Belichenko P.V., Wright E.E., Belichenko N.P., Masliah E., Li H.H., Mobley W.C., Francke U. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol 2009, 514(3):240-258.
10. Ben-Shachar S., Chahrour M., Thaller C., Shaw C.A., Zoghbi H.Y. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus. Hum Mol Genet 2009, 18(13):2431-2442.
11. Blanchart A., De Carlos J.A., López-Mascaraque L. Time frame of mitral cell development in the mice olfactory bulb. J Comp Neurol 2006, 496(4):529-543.
12. Calfa G., Hablitz J.J., Pozzo-Miller L. Network hyperexcitability in hippocampal slices from mecp2 mutant mice revealed by voltage-sensitive dye imaging. J Neurophysiol 2011, 105:1768-1784.
13. Chahrour M., Jung S.Y., Shaw C., Zhou X., Wong S.T., Qin J., Zoghbi H.Y. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008, 320(5880):1224-1229.
14. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 2007, 56(3):422-437.
15. Chan C., Ekberg J.A., Lineburg K.E., Scott S.E., Chehrehasa F., Windus L.C., Claxton C., Mackay-Sim A., Key B., St John J.A. Correction of aberrant axon growth in the developing mouse olfactory bulb. Mol Cell Neurosci 2011, 46:282-295.
16. Chao H.T., Chen H., Samaco R.C., Xue M., Chahrour M., Yoo J., Neul J.L., Gong S., Lu H.C., Heintz N., Ekker M., Rubenstein J.L., Noebels J.L., Rosenmund C., Zoghbi H.Y. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010, 468(7321):263-269.
17. Chao H.T., Zoghbi H.Y., Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 2007, 56(1):58-65.
18. Chapleau C.A., Calfa G.D., Lane M.C., Albertson A.J., Larimore J.L., Kudo S., Armstrong D.L., Percy A.K., Pozzo-Miller L. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiol Dis 2009, 35(2):219-233.
19. Chen R.Z., Akbarian S., Tudor M., Jaenisch R. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001, 27(3):327-331.
20. Chen W.G., Chang Q., Lin Y., Meissner A., West A.E., Griffith E.C., Jaenisch R., Greenberg M.E. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 2003, 302(5646):885-889.
21. Cloutier J.F., Sahay A., Chang E.C., Tessier-Lavigne M., Dulac C., Kolodkin A.L., Ginty D.D. Differential requirements for semaphorin 3F and Slit-1 in axonal targeting, fasciculation, and segregation of olfactory sensory neuron projections. J Neurosci 2004, 24:9087-9096.
22. Cohen D.R., Matarazzo V., Palmer A.M., Tu Y., Jeon O.H., Pevsner J., Ronnett G.V. Expression of MeCP2 in olfactory receptor neurons is developmentally regulated and occurs before synaptogenesis. Mol Cell Neurosci 2003, 22(4):417-429.
23. Cusack S.M., Rohn T.T., Medeck R.J., Irwin K.M., Brown R.J., Mercer L.M., Oxford J.T. Suppression of MeCP2beta expression inhibits neurite extension in PC12 cells. Exp Cell Res 2004, 299(2):442-453.
24. Dani V.S., Chang Q., Maffei A., Turrigiano G.G., Jaenisch R., Nelson S.B. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 2005, 102(35):12560-12565.
25. Degano A.L., Pasterkamp R.J., Ronnett G.V. MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering semaphorin 3F function. Mol Cell Neurosci 2009, 42(3):243-254.
26. Fiala J.C., Spacek J., Harris K.M. Dendritic spine pathology: cause or consequence of neurological disorders?. Brain Res Brain Res Rev 2002, 39(1):29-54.
27. Fukuda T., Itoh M., Ichikawa T., Washiyama K., Goto Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 2005, 64(6):537-544.
28. Imamura F., Greer C.A. Dendritic branching of olfactory bulb mitral and tufted cells: regulation by TrkB. PLoS One 2009, 4(8):e6729.
29. Johnston M.V., Jeon O.H., Pevsner J., Blue M.E., Naidu S. Neurobiology of Rett syndrome: a genetic disorder of synapse development. Brain Dev 2001, 23(Suppl 1):206-213.
30. Jugloff D.G., Jung B.P., Purushotham D., Logan R., Eubanks J.H. Increased dendritic complexity and axonal length in cultured mouse cortical neurons overexpressing methyl-CpG-binding protein MeCP2. Neurobiol Dis 2005, 19(1-2):18-27.
31. Kasowski H.J., Kim H., Greer C.A. Compartmental organization of the olfactory bulb glomerulus. J Comp Neurol 1999, 407(2):261-274.
32. Kaufmann W.E., Moser H.W. Dendritic anomalies in disorders associated with mental retardation. Cereb Cortex 2000, 10(10):981-991.
33. Kim E.J., Simpson P.J., Park D.J., Liu B.Q., Ronnett G.V., Moon C. Leukemia inhibitory factor is a proliferative factor for olfactory sensory neurons. Neuroreport 2005, 16(1):25-28.
34. Kishi N., Macklis J.D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 2004, 27(3):306-321.
35. Kriaucionis S., Paterson A., Curtis J., Guy J., Macleod N., Bird A. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol 2006, 26(13):5033-5042.
36. Larimore J.L., Chapleau C.A., Kudo S., Theibert A., Percy A.K., Pozzo-Miller L. Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis 2009, 34(2):199-211.
37. LaSalle J.M., Goldstine J., Balmer D., Greco C.M. Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry. Hum Mol Genet 2001, 10(17):1729-1740.
38. Lioy D.T., Garg S.K., Monaghan C.E., Raber J., Foust K.D., Kaspar B.K., Hirrlinger P.G., Kirchhoff F., Bissonnette J.M., Ballas N., Mandel G. A role for glia in the progression of Rett's syndrome. Nature 2011, 475:497-500.
39. Maezawa I., Jin L.W. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 2010, 30(15):5346-5356.
40. Maezawa I., Swanberg S., Harvey D., LaSalle J.M., Jin L.W. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 2009, 29(16):5051-5061.
41. Malun D., Brunjes P.C. Development of olfactory glomeruli: temporal and spatial interactions between olfactory receptor axons and mitral cells in opossums and rats. J Comp Neurol 1996, 368(1):1-16.
42. Martinowich K., Hattori D., Wu H., Fouse S., He F., Hu Y., Fan G., Sun Y.E. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 2003, 302(5646):890-893.
43. Matarazzo V., Cohen D., Palmer A.M., Simpson P.J., Khokhar B., Pan S.J., Ronnett G.V. The transcriptional repressor Mecp2 regulates terminal neuronal differentiation. Mol Cell Neurosci 2004, 27(1):44-58.
44. Matarazzo V., Ronnett G.V. Temporal and regional differences in the olfactory proteome as a consequence of MeCP2 deficiency. Proc Natl Acad Sci U S A 2004, 101(20):7763-7768.
45. Matsutani S., Yamamoto N. Differentiation of mitral cell dendrites in the developing main olfactory bulbs of normal and naris-occluded rats. J Comp Neurol 2000, 418(4):402-410.
46. McGill B.E., Bundle S.F., Yaylaoglu M.B., Carson J.P., Thaller C., Zoghbi H.Y. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 2006, 103(48):18267-18272.
47. Medrihan L., Tantalaki E., Aramuni G., Sargsyan V., Dudanova I., Missler M., Zhang W. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 2008, 99(1):112-121.
48. Monteggia L.M., Kavalali E.T. Rett syndrome and the impact of Mecp2 associated transcriptional mechanisms on neurotransmission. Biol Psychiatry 2009, 65(3):204-210.
49. Moretti P., Levenson J.M., Battaglia F., Atkinson R., Teague R., Antalffy B., Armstrong D., Arancio O., Sweatt J.D., Zoghbi H.Y. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 2006, 26(1):319-327.
50. Nuber U.A., Kriaucionis S., Roloff T.C., Guy J., Selfridge J., Steinhoff C., Schulz R., Lipkowitz B., Ropers H.H., Holmes M.C., Bird A. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet 2005, 14(15):2247-2256.
51. Palmer A., Qayumi J., Ronnett G. MeCP2 mutation causes distinguishable phases of acute and chronic defects in synaptogenesis and maintenance, respectively. Mol Cell Neurosci 2008, 37(4):794-807.
52. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35(2):243-254.
53. Simpson P.J., Miller I., Moon C., Hanlon A.L., Liebl D.J., Ronnett G.V. Atrial natriuretic peptide type C induces a cell-cycle switch from proliferation to differentiation in brain-derived neurotrophic factor- or nerve growth factor-primed olfactory receptor neurons. J Neurosci 2002, 22(13):5536-5551.
54. Simpson P.J., Moon C., Kleman A.M., Connolly E., Ronnett G.V. Progressive and inhibitory cell cycle proteins act simultaneously to regulate neurotrophin-mediated proliferation and maturation of neuronal precursors. Cell Cycle 2007, 6(9):1077-1089.
55. Smrt R.D., Eaves-Egenes J., Barkho B.Z., Santistevan N.J., Zhao C., Aimone J.B., Gage F.H., Zhao X. Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiol Dis 2007, 27(1):77-89.
56. Tenne-Brown J., Key B. Errors in lamina growth of primary olfactory axons in the rat and mouse olfactory bulb. J Comp Neurol 1999, 410:20-30.
57. Tropea D., Giacometti E., Wilson N.R., Beard C., McCurry C., Fu D.D., Flannery R., Jaenisch R., Sur M. Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A 2009, 106(6):2029-2034.
58. Urdinguio R.G., Lopez-Serra L., Lopez-Nieva P., Alaminos M., Diaz-Uriarte R., Fernandez A.F., Esteller M. Mecp2-null mice provide new neuronal targets for Rett syndrome. PLoS One 2008, 3(11):e3669.
59. Wood L., Gray N.W., Zhou Z., Greenberg M.E., Shepherd G.M. Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency. J Neurosci 2009, 29(40):12440-12448.
60. Zhou Z., Hong E.J., Cohen S., Zhao W.N., Ho H.Y., Schmidt L., Chen W.G., Lin Y., Savner E., Griffith E.C., Hu L., Steen J.A., Weitz C.J., Greenberg M.E. Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 2006, 52(2):255-269.
61. Zoghbi H.Y. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 2003, 302(5646):826-830.